Increased COVID-19 infection risk, COVID-19 vaccine inaccessibility, and unacceptability: Worrisome trio for patients with substance abuse disorders.  Yasmin F, Najeeb H, Asghar MS, Ullah I, Islam SMS.  J Glob Health. 2021 Oct 2;11:03106…

Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19.  Martin A, Raber JP, Shayer D, Lai D, Goodcoff A, Kannikal J, Raja AS, He S.  Digit Health. 2021 Oct 19;7:20552076211048985. doi: 10.1177/20552076211048…

Treating an Epidemic During a Pandemic: Experience Treating Opioid Use Disorder at the Baltimore Convention Center Field Hospital.  Chamberlain, C., Siddiqui, Z., Chaudhary, M., & Kantsiper, M. (2021).  Disaster Medicine and Public H…

Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19.  Kelley AT, Dungan MT, Gordon AJ. J Addict Med. 2021 Sep-Oct 01;15(5):439-440. doi: 10.1097/ADM.000000000000…

The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report.  Collins AB, Beaudoin FL, Samuels EA, Wightman R, Baird J.  J Addict Med. 2021 Sep-Oct 01;15(5):432-434. doi: 10.1097/ADM…

Increasing opium use in Iran in response to unsubstantiated rumors that it protects against COVID-19.  Khosravi, M. (2021),  Addiction. Accepted Author Manuscript. doi.org/10.1111/add.15706 https://onlinelibrary.wiley.com/doi/abs/10.111…